SEC Company Response from PAVmed Inc. (PAVM) (CIK 0001624326) (PAVM) — Apr 15, 2020
PAVmed Inc. (PAVM) (CIK 0001624326)
Date: April 15, 2020 · CIK: 0001624326 · Accession: 0001493152-20-006461
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-235335
Letter
Re: PAVmed Inc.
PAVMED INC.
One Grand Central Place, Suite 4600
New York, New York 10165
April 15, 2020
Securities and Exchange Commission
Division of Corporation Finance
Washington, District of Columbia 20549
Registration Statement on Form S-3
Originally Filed December 3, 2019
File No. 333-235335
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, PAVmed Inc. hereby requests acceleration of the effectiveness of the above-referenced Registration Statement (File No. 333-235335), so that such Registration Statement will become effective at 4:30 p.m. Eastern Time on Friday, April 17, 2020, or as soon thereafter as practicable.
Sincerely,
PAVMED INC.
Show Raw Text
CORRESP
1
filename1.htm
PAVMED
INC.
One
Grand Central Place, Suite 4600
New
York, New York 10165
April
15, 2020
Securities
and Exchange Commission
Division
of Corporation Finance
Washington,
District of Columbia 20549
Re:
PAVmed
Inc.
Registration
Statement on Form S-3
Originally
Filed December 3, 2019
File
No. 333-235335
Ladies
and Gentlemen:
Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, PAVmed Inc. hereby requests acceleration of the effectiveness
of the above-referenced Registration Statement (File No. 333-235335), so that such Registration Statement will become effective
at 4:30 p.m. Eastern Time on Friday, April 17, 2020, or as soon thereafter as practicable.
Sincerely,
PAVMED INC.
By:
/s/
Dennis M. McGrath
Name:
Dennis
M. McGrath
Title:
President
and Chief Financial Officer